€412,797
▲ Purchases (25 ops.)
Insider track record Other Across 19 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Discover the complete record of transactions filed by Mendelson Daniel Newman. Director active across 1 company, notably Champions Oncology, INC.. Aggregated, 25 disclosures have been recorded. Split: 25 buys · 0 sell. Total volume traded: €413k. History available since 20 September 2023. The latest transaction was disclosed on 12 January 2024 (Acquisition). Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations 25 total
1,000 shares @ US$6.50 1.4% of flow Common Stock SEC:0001628280-24-001334:0
Ideal exit: 8 Oct 2024 (T+270) 2,000 shares @ US$6.27 2.8% of flow Common Stock SEC:0001628280-24-001231:0
Ideal exit: 7 Oct 2024 (T+270) 2,944 shares @ US$6.31 4.1% of flow Common Stock SEC:0001628280-24-001118:0
Ideal exit: 6 Oct 2024 (T+270) 3,000 shares @ US$6.25 4.1% of flow Common Stock SEC:0001628280-24-001002:0
Ideal exit: 5 Oct 2024 (T+270) 1,000 shares @ US$6.15 1.4% of flow Common Stock SEC:0001628280-24-000896:0
Ideal exit: 4 Oct 2024 (T+270) 2,000 shares @ US$6.09 2.7% of flow Common Stock SEC:0001628280-24-000825:0
Ideal exit: 1 Oct 2024 (T+270) 3,000 shares @ US$6.12 4.1% of flow Common Stock SEC:0001628280-24-000820:0
Ideal exit: 30 Sept 2024 (T+270) 500 shares @ US$5.83 0.6% of flow Common Stock SEC:0001628280-24-000388:0
Ideal exit: 29 Sept 2024 (T+270) 2,500 shares @ US$4.92 2.7% of flow Common Stock SEC:0001628280-23-042662:0
Ideal exit: 16 Sept 2024 (T+270) 2,100 shares @ US$4.82 2.2% of flow Common Stock SEC:0001628280-23-042467:0
Ideal exit: 15 Sept 2024 (T+270) 5,000 shares @ US$4.75 5.3% of flow Common Stock SEC:0001628280-23-042096:0
Ideal exit: 14 Sept 2024 (T+270) 5,000 shares @ US$6.22 7.1% of flow Common Stock SEC:0001628280-23-034407:0
Ideal exit: 24 Jun 2024 (T+270) 4,000 shares @ US$6.16 5.7% of flow Common Stock SEC:0001628280-23-034409:0
Ideal exit: 25 Jun 2024 (T+270) 1,500 shares @ US$5.95 2.1% of flow Common Stock SEC:0001628280-23-034405:0
Ideal exit: 23 Jun 2024 (T+270) 5,000 shares @ US$6.40 7.3% of flow Common Stock SEC:0001628280-23-034348:0
Ideal exit: 7 Jul 2024 (T+270) 1,100 shares @ US$6.41 1.6% of flow Common Stock SEC:0001628280-23-034231:0
Ideal exit: 6 Jul 2024 (T+270) 1,530 shares @ US$6.48 2.3% of flow Common Stock SEC:0001628280-23-034119:0
Ideal exit: 2 Jul 2024 (T+270) 2,000 shares @ US$6.47 3.0% of flow Common Stock SEC:0001628280-23-034004:0
Ideal exit: 1 Jul 2024 (T+270) 5,000 shares @ US$6.40 7.4% of flow Common Stock SEC:0001628280-23-033842:0
Ideal exit: 30 Jun 2024 (T+270) 2,500 shares @ US$6.30 3.6% of flow Common Stock SEC:0001628280-23-033843:0
Ideal exit: 29 Jun 2024 (T+270) 5,000 shares @ US$5.65 13.0% of flow Common Stock SEC:0001628280-23-033077:0
Ideal exit: 22 Jun 2024 (T+270) 4,018 shares @ US$5.51 9.4% of flow Common Stock SEC:0001628280-23-032919:0
Ideal exit: 16 Jun 2024 (T+270) 5,000 shares @ US$5.28 11.1% of flow Common Stock SEC:0001628280-23-032920:0
Ideal exit: 15 Jun 2024 (T+270) 5,000 shares @ US$5.51 11.7% of flow Common Stock SEC:0001628280-23-032918:0
Ideal exit: 17 Jun 2024 (T+270) 3,812 shares @ US$5.50 7.0% of flow Common Stock SEC:0001628280-23-032917:0
Ideal exit: 18 Jun 2024 (T+270)